| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |